Clinical Trial Update: Use of Dexmedetomidine in Children Undergoing Oral Maxillofacial Surgery to Decrease Emergence Delirium [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dexmedetomidine to reduce emergence delirium in children undergoing oral maxillofacial surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Delirium | Phase 4 | Status: WITHDRAWN